HSBC analyst Rajesh Kumar upgraded GlaxoSmithKline (GSK:LN) (NYSE: GSK) from Reduce to Hold with a price target of GBP18.60 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change Intl Ratings Upgrades